A Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Gaucher Disease

NCT00430625 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Gaucher Disease, Type 1

Interventions

BIOLOGICAL: VPRIV ®,

Sponsor

Shire